ANRO in the 13F filings
Alto Neuroscience Inc · CUSIP 02157Q109
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 15 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 17
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 0 listed it in both
- Shares listed
- 2,793,539
- combined, among listed positions
- Reported value
- $63m
- combined, at the quarter end
Among the 91 comparable managers: 11 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -552,049.
Managers listing ANRO in Q1 2026
17 of 17 holders
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 371,208 shares now+340,980
- Millennium Management LLCexisting position · 821,982 shares now+191,997
- Susquehanna International Group LLPexisting position · 238,498 shares now+120,342
- Two Sigma Investments LPexisting position · 216,099 shares now+75,782
- Brevan Howard Capital Management LPnew position · 38,782 shares now+38,782
Reductions
- Point72 Asset Management LPexisting position · 503,087 shares now-1,103,867
- Jane Street Group LLCexisting position · 30,058 shares now-163,983
- D. E. Shaw & Co.existing position · 45,343 shares now-79,452
- Marshall Wace LLPexisting position · 176,347 shares now-16,762
- Wellington Management Group LLPexisting position · 59,799 shares now-9,217
New positions and exits
New (3)
Exited (2)
- ExodusPoint Capital Management LPwas $334k
- Citadel Advisors LLCwas $231k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2024 | 3 | $29m | 3 | 0 |
| Q2 2024 | 2 | $10m | 1 | 0 |
| Q3 2024 | 2 | $15m | 1 | 0 |
| Q1 2026 | 1 | $373k | 11 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ANRO and LLY →ANRO and TMO →ANRO and JNJ →Choose a stock to compare with ANRO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ANRO, latest filings →Back to the 13F Explorer →